<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We measured the <z:chebi fb="2" ids="33699">mRNA</z:chebi> and protein expression of the key gluconeogenic enzymes in human liver biopsies, and found that only hepatic <z:chebi fb="1" ids="15361">pyruvate</z:chebi> carboxylase protein levels related strongly with glycemia </plain></SENT>
<SENT sid="1" pm="."><plain>We assessed the role of <z:chebi fb="1" ids="15361">pyruvate</z:chebi> carboxylase in regulating <z:chebi fb="105" ids="17234">glucose</z:chebi> and <z:chebi fb="23" ids="18059">lipid</z:chebi> metabolism in rats through a loss-of-function approach using a specific antisense oligonucleotide (ASO) to decrease expression predominantly in liver and adipose tissue </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="1" ids="15361">Pyruvate</z:chebi> carboxylase ASO reduced plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> concentrations and the rate of endogenous <z:chebi fb="105" ids="17234">glucose</z:chebi> production in vivo </plain></SENT>
<SENT sid="3" pm="."><plain>Interestingly, <z:chebi fb="1" ids="15361">pyruvate</z:chebi> carboxylase ASO also reduced <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e>, plasma <z:chebi fb="23" ids="18059">lipid</z:chebi> concentrations, and <z:hpo ids='HP_0001397'>hepatic steatosis</z:hpo> in high-fat-fed (HFF) rats and improved hepatic insulin sensitivity </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="1" ids="15361">Pyruvate</z:chebi> carboxylase ASO had similar effects in ZDF rats </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="1" ids="15361">Pyruvate</z:chebi> carboxylase ASO did not alter de novo fatty acid synthesis, lipolysis, or hepatocyte fatty acid oxidation </plain></SENT>
<SENT sid="6" pm="."><plain>In contrast, the <z:chebi fb="23" ids="18059">lipid</z:chebi> phenotype was attributed to a decrease in hepatic and adipose <z:chebi fb="3" ids="17754">glycerol</z:chebi> synthesis, which is important for fatty acid esterification when dietary fat is in excess </plain></SENT>
<SENT sid="7" pm="."><plain>Tissue specific inhibition of <z:chebi fb="1" ids="15361">pyruvate</z:chebi> carboxylase is a potential therapeutic approach for nonalcoholic <z:hpo ids='HP_0001397'>fatty liver</z:hpo> disease, hepatic <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>